Medicare’s $50/month GLP-1 Bridge: Who Qualifies for Coverage

If you live with obesity and have Medicare Part D, a new time-limited coverage pathway called the Medicare GLP-1 Bridge started on July 1, 2026. It runs through Dec. 31, 2027.

The goal: help eligible Medicare beneficiaries get certain prescription GLP-1 weight-management medicines for a more predictable cost—$50 per month—using a process that works outside the usual Part D coverage/payment flow.

What the Medicare GLP-1 Bridge is (and when it runs)

CMS describes the Medicare GLP-1 Bridge as a short-term demonstration that provides eligible Medicare Part D beneficiaries access to certain GLP-1 drugs between July 1, 2026 and Dec. 31, 2027. CMS also notes that the Bridge operates outside the Medicare Part D benefit’s coverage and payment flow—so Part D plan sponsors don’t carry the usual risk for these Bridge GLP-1 drugs and don’t have to opt in for eligible beneficiaries to access them. CMS also plans to use a single central processor to manage prior authorization, claims adjudication, and payment to pharmacies during the Bridge period.

What it covers: specific GLP-1 weight-management medicines

According to the Medicare GLP-1 Bridge fact sheet, the Bridge covers these GLP-1 drugs:

Foundayo (tablet)
Wegovy (injection or tablet)
Zepbound (KwikPen only) — the fact sheet specifies that the single-dose Zepbound pen and Zepbound vials are NOT covered under the Bridge

The fact sheet also describes these covered products as GLP-1 medicines with certain active ingredients (including semaglutide, tirzepatide, and others). Coverage is tied to the specific products and formulations listed above.

What the “$50/month” copay means

For eligible beneficiaries, CMS states the copay is $50 and that it is provided outside the Part D benefit payment flow and coverage. Practically, CMS notes:

The Part D deductible does not apply to Bridge drugs
No part of the $50 copay counts toward TrOOP (your Medicare drug plan true out-of-pocket costs)
There is no low-income subsidy (LIS) provided for LIS beneficiaries under the Bridge
The Bridge drugs aren’t eligible for the Medicare Prescription Payment Plan

Who qualifies: Medicare plan type + medical criteria

To get the GLP-1 drugs listed for the Medicare GLP-1 Bridge, the fact sheet says you must meet all four requirements:

1) You have Medicare Part D drug coverage

You must have Medicare Part D drug coverage. The fact sheet also says you’re not eligible if your only Medicare coverage is through certain special plan types (for example, private fee-for-service plans, cost contract plans, or a PACE organization). If you’re not sure what type of plan you have, call 1-800-MEDICARE.

2) You’re not receiving GLP-1 through your Medicare drug plan

You’re not eligible if you would be receiving a GLP-1 drug through your Medicare drug plan under the usual Part D pathway. If you’ve been using a GLP-1 drug paid for by your Medicare drug plan for any reason, the fact sheet says you need to keep getting your GLP-1 through your plan.

3) You meet the age and medical “exclusion” criteria

The fact sheet includes the following:

You must be at least 18 years old
You must not have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease

4) You meet the BMI-based criteria

To qualify, the fact sheet requires that at least one of these BMI criteria is true:

BMI ≥ 35
BMI ≥ 30 plus certain conditions (including specific types of heart failure, hard-to-control high blood pressure, or chronic kidney disease stage 3a or above)
BMI ≥ 27 plus certain conditions (including prediabetes, history of heart attack or stroke, or blocked arteries in the legs or arms)

CDC notes that BMI is calculated from height and weight and is used as a screening measure—it’s one tool clinicians and programs use to identify risk and eligibility.

How to get it: the practical approval flow

The Bridge isn’t just an automatic Part D benefit. The Medicare.gov fact sheet describes this practical sequence:

Talk to your doctor about whether a GLP-1 drug is right for you and whether you qualify for the Bridge
If a covered GLP-1 is appropriate, your doctor sends the prescription to the pharmacy
Your pharmacy may reach out to request your Medicare ID number (printed on your card). If you don’t have your card, the fact sheet says the pharmacist can look up your number using the last four digits of your Social Security Number
After the pharmacy receives confirmation that you are eligible for Medicare GLP-1 Bridge, your doctor needs to submit a form to get approval from Medicare
You’ll also receive a letter from Medicare letting you know your medicine is covered
Pick up your medicine and pay $50 for a one-month supply

For refills: the fact sheet says you don’t need a new approval from Medicare as long as you stay on the same drug, even if your dose changes.

What to expect from obesity treatment (and a key note for older adults)

Obesity is often treated as a long-term condition, which means medication is typically used with an ongoing management approach rather than as a short “fix.” Professional guidance on obesity pharmacotherapy emphasizes combining medications with lifestyle/behavior strategies when feasible and monitoring response and side effects.

For older adults (65+): the $50 Bridge copay is specific to the program, but clinical suitability still matters—especially with multiple health conditions and other medications. Ask your prescriber what risks and benefits apply to your situation and which monitoring you’ll need.

Safety basics to discuss with your clinician

GLP-1 medicines can cause side effects, most commonly stomach-related symptoms (for example, nausea and diarrhea). For any specific medicine, the prescribing information includes product-specific warnings and contraindications. For example, MedlinePlus notes that semaglutide has important warnings related to certain thyroid tumors and genetic conditions. Before starting, ask your clinician/pharmacist to review the medication guide for the exact Bridge product you’re getting.

Bottom line checklist: questions to ask your prescriber or pharmacy

Do I meet the Bridge BMI criteria? Ask what your BMI is and which qualifying option you fit.
Am I excluded due to any conditions? (Type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease.)
Does my Medicare drug plan already cover a GLP-1 for me? If yes, the fact sheet says Bridge access works differently.
Which Bridge-covered product and formulation am I prescribed? Confirm that the exact formulation matches the Bridge list (for Zepbound, KwikPen only).
What documents or steps are required for Medicare approval? Who submits the form after pharmacy confirmation?
What will I pay at the pharmacy? Confirm $50 for a one-month supply and what to expect for refills if your dose changes.
If I don’t qualify under the Bridge, what other coverage options might I have?

If you want more official, beneficiary-facing details, the Medicare GLP-1 Bridge fact sheet is available through Medicare.gov.

Key sources

Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.

This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.